Skip to contentA
Acadia Healthcare Company, Inc.
A
ACHCAcadia Healthcare Company, Inc. Q3 2021 · 10-Q
Revenue$587.56M$587.56M+7.2% vs Q3 2020 Net Income$66.13M$66.13M+78.7% vs Q3 2020 EPS Diluted$0.73$0.73+73.8% vs Q3 2020 Operating Cash Flowderived$110,117,000−46.9% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acadia Healthcare Company, Inc. · CIK 1520697 · Engraved from SEC EDGAR
Free Cash Flowderived$66,446,000−56.5% Margins · derivedNet margin11.3%+4.5 pt vs Q3 2020
ended Sep 30, 2021 · filed Oct 29, 2021 · 29 d after period end